This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Asahi Kasei Pharma Corporation, Vernalis (R&D) Ltd. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 84 
1 out of 4 Years Active: 2026
Title: Kenichiro Takaba: Innovator in Medicinal Chemistry
Introduction
Kenichiro Takaba is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds with therapeutic potential. Although he currently holds no granted patents, his work continues to influence the industry.
Latest Patent Applications
One of Kenichiro Takaba's recent patent applications is titled "Pyrimidine- and Nitrogen-containing Bicyclic Compound." This application describes a compound represented by the general formula (1) or a salt thereof, which exhibits superior IRAK-4 inhibitory activity. This compound is useful as an active ingredient in medicaments for the prophylactic and therapeutic treatment of diseases related to IRAK-4 inhibition.
Conclusion
Kenichiro Takaba's innovative work in medicinal chemistry highlights his commitment to advancing healthcare solutions. His contributions, although not yet reflected in granted patents, demonstrate the potential impact of his research on future therapeutic developments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile